Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2004 October;56(5) > Minerva Pediatrica 2004 October;56(5):469-80

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEWS  


Minerva Pediatrica 2004 October;56(5):469-80

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Anti-IgE therapy in children with asthma

Milgrom H.


PDF  


The prevalence of asthma continues to grow rapidly among children in areas undergoing urbanization. Current pharmacotherapy for asthma reduces inflammation and provides symptomatic relief, but it does not work for all patients and it does not entirely suppress the underlying disease. For these reasons new therapeutic approaches are still needed. Anti-IgE, the newest therapeutic modality for asthma, a biologic agent to control allergic disorders, represents a fundamentally new concept in treatment.

top of page

Publication History

Cite this article as

Corresponding author e-mail